Page last updated: 2024-11-02

piracetam and Spinocerebellar Ataxias

piracetam has been researched along with Spinocerebellar Ataxias in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research Excerpts

ExcerptRelevanceReference
"He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam."1.33Suppression of myoclonus in SCA2 by piracetam. ( Barbieri, F; de Falco, A; De Michele, G; De Rosa, A; Filla, A; Rinaldi, C; Striano, P; Striano, S; Tucci, T, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Orsucci, D1
Ienco, EC1
Rocchi, A1
Siciliano, G1
Mancuso, M1
Bonuccelli, U1
De Rosa, A1
Striano, P1
Barbieri, F1
de Falco, A1
Rinaldi, C1
Tucci, T1
Striano, S1
Filla, A1
De Michele, G1

Other Studies

2 other studies available for piracetam and Spinocerebellar Ataxias

ArticleYear
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:10

    Topics: Anticonvulsants; Female; Humans; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Mutation; My

2013
Suppression of myoclonus in SCA2 by piracetam.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:1

    Topics: Adult; Ataxia; Ataxins; Dose-Response Relationship, Drug; Gait Ataxia; Humans; Infusions, Intravenou

2006